Karch / Drummer Karch's Pathology of Drug Abuse, Fifth Edition

5. Auflage 2015
ISBN: 978-1-4398-6147-9
Verlag: Taylor & Francis
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 906 Seiten

The Pathology of Drug Abuse, Fifth Edition is a comprehensive yet accessible guide to the pathology, toxicology, and pharmacology of commonly abused drugs. The book also offers detailed information on the origin, history, and production techniques used to make these drugs. As in the first edition, emphasis remains focused on the investigation of drug-related deaths and on practical approaches to the detection of drug abuse. The medical complications associated with each of the abused drugs are discussed in some detail as well.
Individual chapters examine cocaine and other naturally occurring stimulants, synthetic stimulants, hallucinogens, narcotics, anabolic steroids, and solvent abuse. Approximately 800 new references have been added since the publication of the first edition. Numerous new photomicrographs and drawings have been added, and many of the illustrations from the first edition have been redrawn to enhance clarity.

Steven B. Karch discusses the book in a video on the CRC Press YouTube channel.

Zielgruppe

Forensic scientists, toxicologists, pathologists, medical examiners, and criminal justice professionals.

Autoren/Hrsg.

Karch, Steven B.

Karch, Md

Drummer, Olaf

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Rechtswissenschaften Strafrecht Rechtsmedizin, Forensik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pathologie, Cytopathologie, Histopathologie

Inhaltsverzeichnis

Cocaine
Natural stimulants
Synthetic stimulants
Hallucinogens
Emerging new designer drugs
Opiates and opinoids
Dissociative anesthetics
Anabolic steroids
Solvents

Über Autor(innen)

Steven B. Karch is a fellow in several forensic and toxicological societies and has served many years as consultant to both the legal community and the pharmaceutical industry in the United States and the United Kingdom.